Estée Lauder Companies
EL
$80.01
-0.34%
The Estée Lauder Companies Inc. is a global leader in the prestige beauty market, operating across key segments including skincare, makeup, fragrance, and hair care, with iconic brands such as Estée Lauder, Clinique, M.A.C, and La Mer. The company is distinguished by its portfolio of premium brands, a dominant position in global travel retail, and a diversified geographic footprint across the Americas, EMEA, and Asia-Pacific. The current investor narrative is heavily focused on the company's ongoing turnaround efforts, as it grapples with a volatile recovery in key markets like China and travel retail, while attempting to restore consistent profitability and revenue growth following a period of significant earnings pressure and a sharp stock price decline in early 2026.…
EL
Estée Lauder Companies
$80.01
Related headlines
EL 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Estée Lauder Companies's 12-month outlook, with a consensus price target around $104.01 and implied upside of +30.0% versus the current price.
Average Target
$104.01
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$64 - $104
Analyst target range
Analyst coverage for EL is limited, with only 7 analysts providing estimates according to the data, which is surprisingly low for a company of its market cap. The consensus sentiment appears mixed, with recent institutional ratings showing a blend of 'Buy' or 'Overweight' calls (Deutsche Bank, JP Morgan, Citigroup upgrade) and 'Hold' or 'Equal Weight' ratings (Wells Fargo, Barclays, Telsey Advisory). The average target price is not explicitly provided in the data, but the estimated EPS consensus for the forward period is $5.76, ranging from a low of $5.65 to a high of $5.84. The target price range implied by the EPS estimates, when combined with the forward PE of 25.26x, suggests a potential price range, but without explicit price targets, the implied upside/downside is unclear. The wide dispersion in analyst actions—from upgrades to cautious holds—signals high uncertainty and a lack of strong conviction on the near-term path. The limited number of covering analysts (7) for a large-cap stock indicates that institutional interest may be waning or that the investment story is in flux, which can contribute to higher volatility and less efficient price discovery as the market seeks clarity on the turnaround's success.
Bulls vs Bears: EL Investment Factors
The investment debate for Estée Lauder centers on a classic turnaround story: a historically premium franchise trading at distressed valuation multiples due to severe but potentially transient profitability issues. The bull case is anchored in the company's intact pricing power (73.9% gross margin), strong cash generation ($1.14B FCF), and a valuation (2.04x PS) that appears to price in deep pessimism. The bear case highlights the very real risks of a prolonged downturn, evidenced by negative margins, high financial leverage (D/E of 2.44), and volatile earnings. Currently, the bear side holds stronger evidence, as the fundamental deterioration is severe and recent quarterly improvements require sustained confirmation. The single most important tension is whether the Q2 FY26 profitability rebound marks the beginning of a durable operational recovery or merely a temporary respite before further earnings pressure. The resolution of this tension—specifically, the trajectory of net margins and ROE over the next two quarters—will most decisively determine the investment thesis.
Bullish
- Strong Gross Margin & Pricing Power: The company maintains a robust gross margin of 73.89%, indicating its premium brand portfolio retains significant pricing power despite recent earnings pressure. This high-margin structure provides a solid foundation for profitability recovery as operational costs are brought under control.
- Significant Free Cash Flow Generation: Estée Lauder generates substantial free cash flow, with TTM FCF of $1.14 billion. This strong cash generation provides the internal resources needed to service its high debt load, fund operations, and support the turnaround without immediate liquidity concerns.
- Valuation at Multi-Year Lows: The stock trades at a PS ratio of 2.04x, a sharp compression from its recent peak of 8.95x in Q2 FY26. This depressed multiple, near the lower end of its historical range, suggests substantial pessimism is priced in, creating a potential value opportunity if fundamentals stabilize.
- Quarterly Profitability Rebound: Q2 FY26 showed a marked improvement, with net income of $162 million and an operating margin of 6.70%, a stark reversal from the -$590 million net loss in the year-ago quarter. This sequential recovery is a critical early signal that turnaround efforts may be gaining traction.
Bearish
- Severe Profitability & ROE Destruction: The company reports a deeply negative trailing net margin of -7.93% and a Return on Equity of -29.31%, reflecting significant shareholder value destruction. The negative trailing EPS of -$0.04 underscores the depth of recent earnings pressure despite the premium brand portfolio.
- Highly Leveraged Balance Sheet: Estée Lauder carries a high debt-to-equity ratio of 2.44, indicating a leveraged capital structure that increases financial risk. This leverage amplifies downside risk if the operational turnaround falters or if interest rates remain elevated, pressuring cash flows.
- Volatile Revenue & Earnings Trend: Revenue growth remains inconsistent, with a recent quarterly YoY increase of 5.84% following a period of significant losses, including a -$546 million net loss in Q4 FY25. This volatility, coupled with a -14.7% prior-year net income decline, highlights the fragility of the recovery narrative.
- Elevated Beta & Market Underperformance: The stock's beta of 1.211 makes it 21% more volatile than the broader market, contributing to its severe -43.79% drawdown from its peak. It has underperformed the SPY by -34.25% over the last three months, indicating weak relative strength and high sensitivity to market stress.
EL Technical Analysis
The stock is in a pronounced downtrend, having declined 25.83% over the last three months and 8.96% over the last six months, despite a positive 26.09% return over the past year. As of the latest close at $80.28, the stock is trading approximately 34% above its 52-week low of $62.57 but 34% below its 52-week high of $121.64, positioning it in the lower half of its annual range and suggesting a deep correction from previous highs. The recent 1-month price change of +4.80% offers a glimmer of positive momentum, but this recovery is modest against the backdrop of the severe 3-month decline and underperformance versus the market, as evidenced by a -34.25% 3-month relative strength versus the SPY. Recent momentum shows a tentative stabilization, with the stock rising 4.80% over the past month, which diverges from the sharp -25.83% drop over the prior three months. This could signal a potential short-term bottoming process or a pause in the selling pressure, though the stock's beta of 1.211 indicates it is 21% more volatile than the broader market, contributing to its significant drawdown of -43.79% from its peak. The positive 1-month move is a critical technical development but requires confirmation through a sustained move above key resistance levels to suggest a meaningful trend reversal. Key technical support is anchored at the 52-week low of $62.57, while major resistance sits near the 52-week high of $121.64. A decisive break below the $62.57 support would signal a continuation of the bearish trend and potentially open the door to further declines. Conversely, a sustained move above the recent recovery highs near $87-88 (from early May 2026) is needed to challenge the downtrend. The stock's elevated beta of 1.21 confirms it is a high-volatility name, which investors must factor into risk management and position sizing, especially during periods of market stress.
Beta
1.21
1.21x market volatility
Max Drawdown
-43.8%
Largest decline past year
52-Week Range
$63-$122
Price range past year
Annual Return
+22.8%
Cumulative gain past year
| Period | EL Return | S&P 500 |
|---|---|---|
| 1m | +5.0% | +4.0% |
| 3m | -28.7% | +8.2% |
| 6m | -6.9% | +11.5% |
| 1y | +22.8% | +24.3% |
| ytd | -25.1% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EL Fundamental Analysis
Revenue growth has shown signs of recovery but remains inconsistent; the most recent quarterly revenue of $4.24 billion for Q2 FY26 represents a 5.84% year-over-year increase, a positive reversal from the -14.7% decline in net income reported in the same quarter a year prior. However, examining the segment data, Skin Care remains the dominant driver at $2.05 billion (49% of sales), followed by Makeup at $1.16 billion (29%), with Fragrance and Hair Care contributing smaller portions. The sequential improvement in top-line growth from the prior quarter's $3.48 billion is a positive signal, but the multi-quarter trend reveals volatility, with a significant net loss of -$546 million reported in Q4 FY25. Profitability is under severe pressure, with the company reporting a trailing twelve-month net margin of -7.93% and a diluted EPS of -$0.04. The most recent quarterly net income of $162 million (Q2 FY26) and operating margin of 6.70% show a return to profitability, a stark improvement from the -$590 million net loss in Q2 FY25. Gross margin remains robust at 73.89%, indicating the company's pricing power in prestige beauty is intact, but operating expenses have weighed heavily on the bottom line. The path to sustained profitability hinges on continued margin expansion and cost discipline. The balance sheet carries significant financial risk, with a high debt-to-equity ratio of 2.44, indicating a leveraged capital structure. However, liquidity appears adequate with a current ratio of 1.30. A key positive is the generation of substantial free cash flow, with TTM FCF reported at $1.14 billion, providing the company with internal resources to service debt and fund operations. The Return on Equity is deeply negative at -29.31%, reflecting the recent period of net losses and shareholder value destruction, underscoring the critical need for the operational turnaround to gain traction.
Quarterly Revenue
$4.2B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.76%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EL Overvalued?
Given the negative trailing net income and EPS, the primary valuation metric is the Price-to-Sales (PS) ratio. The stock currently trades at a trailing PS ratio of 2.04x and an EV/Sales of 2.39x. The forward PE ratio of 25.26x, based on estimated EPS, suggests the market is pricing in a significant recovery to profitability, creating a large gap with the negative trailing PE of -25.68x. Compared to industry averages, Estée Lauder's valuation presents a mixed picture. While specific sector averages are not provided in the data, a PS ratio around 2.0x for a global prestige beauty leader with a 73.9% gross margin could be considered reasonable if growth normalizes. The forward PE of 25.3x, however, implies a premium growth expectation relative to many mature consumer staples companies, which must be justified by a successful execution of its turnaround and a return to historic levels of earnings power. Historically, the stock's valuation has compressed significantly from its peaks. For instance, the PS ratio was as high as 8.95x as recently as Q2 FY26 (Dec 2025) and above 10x in prior years. The current PS of 2.04x is near the lower end of its multi-year historical range, suggesting the market has priced in substantial pessimism. This depressed multiple could represent a value opportunity if fundamentals stabilize, but it also reflects legitimate concerns over the company's earnings trajectory and leverage, leaving little room for further disappointment.
PE
-25.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -533x~438x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
184.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company's balance sheet is highly leveraged with a debt-to-equity ratio of 2.44, which increases refinancing risk and interest expense pressure in a higher-rate environment. Profitability is fragile, with a trailing net margin of -7.93% and a deeply negative ROE of -29.31%, indicating the turnaround is far from complete. Revenue concentration, while diversified by segment, faces volatility in key markets like China and travel retail, as seen in the -14.7% net income decline a year prior. The company's valuation (forward PE of 25.3x) is entirely dependent on a successful return to sustained earnings growth, creating binary downside if execution falters.
Market & Competitive Risks are elevated. The stock's high beta of 1.21 makes it susceptible to broad market sell-offs, as evidenced by its -34.25% 3-month underperformance versus the SPY. Valuation compression risk is significant; while the current PS of 2.04x is low historically, it could compress further if growth disappoints, given the stock traded above a 10x PS multiple in prior years. Competitive pressures in the prestige beauty space are intense, and the company's dependence on a recovery in travel retail (a key segment) exposes it to macroeconomic and consumer discretionary spending headwinds. The limited analyst coverage (7 analysts) can lead to higher volatility and less efficient price discovery.
Worst-Case Scenario involves a failure of the operational turnaround to gain traction, leading to consecutive quarterly earnings misses. This could trigger a liquidity crisis as high debt servicing costs ($82M interest expense in Q2 FY26) collide with sustained negative net income, forcing asset sales or equity dilution. A simultaneous downturn in the key Asia-Pacific market (32% of sales) and travel retail would exacerbate top-line pressure. In this adverse scenario, the stock could realistically re-test and break below its 52-week low of $62.57, representing a downside of approximately -22% from the current price of $80.28. A re-rating to an even lower sales multiple could push losses toward -30% to -35%.
